Journal article · 2025 · Open access
Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease
Nature Medicine, 31(5), 1604–1616 · Published 6 March 2025 · DOI 10.1038/s41591-025-03574-1
In brief
“Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease” is a 2025 journal article by Lynn van Olst and 22 co-authors, published in Nature Medicine. OpenAlex counts 185 citations as of 18 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Nature Medicine.
- Citations
- 185
- Most cited in
- 2026 (119)
- Field-weighted impact
- 46.89
- References
- 58
- Authors
- 23
Abstract
Alzheimer's disease (AD) therapies utilizing amyloid-β (Aβ) immunization have shown potential in clinical trials. Yet, the mechanisms driving Aβ clearance in the immunized AD brain remain unclear. Here, we use spatial transcriptomics to explore the effects of both active and passive Aβ immunization in the AD brain. We compare actively immunized patients with AD with nonimmunized patients with AD and neurologically healthy controls, identifying distinct microglial states associated with Aβ clearance. Using high-resolution spatial transcriptomics alongside single-cell RNA sequencing, we delve deeper into the transcriptional pathways involved in Aβ removal after lecanemab treatment. We uncover spatially distinct microglial responses that vary by brain region. Our analysis reveals upregulation of the triggering receptor expressed on myeloid cells 2 (TREM2) and apolipoprotein E (APOE) in microglia across immunization approaches, which correlate positively with antibody responses and Aβ removal. Furthermore, we show that complement signaling in brain myeloid cells contributes to Aβ clearance after immunization. These findings provide new insights into the transcriptional mechanisms orchestrating Aβ removal and shed light on the role of microglia in immune-mediated Aβ clearance. Importantly, our work uncovers potential molecular targets that could enhance Aβ-targeted immunotherapies, offering new avenues for developing more effective therapeutic strategies to combat AD.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
van Olst, L., Simonton, B., Edwards, A. J., Forsyth, A. V., Boles, J. S., Jamshidi, P., Watson, T. H., Shepard, N., Krainc, T., Argue, B. M., Zhang, Z., Kuruvilla, J., Camp, L., Li, M., Xu, H., Norman, J. L., Cahan, J. G., Vassar, R. J., Chen, J., . . . Gate, D. (2025). Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease. Nature Medicine, 31(5), 1604–1616. https://doi.org/10.1038/s41591-025-03574-1
MLA 9
van Olst, Lynn, et al. “Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease.” Nature Medicine, vol. 31, no. 5, 2025, pp. 1604–1616. https://doi.org/10.1038/s41591-025-03574-1.
Chicago
van Olst, Lynn, Brooke Simonton, Alex J. Edwards, Anne V. Forsyth, Jake Sondag Boles, Pouya Jamshidi, Thomas H. Watson, et al. 2025. “Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease.” Nature Medicine 31 (5): 1604–1616. https://doi.org/10.1038/s41591-025-03574-1.
Harvard
van Olst, L. et al. (2025) ‘Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease’, Nature Medicine, 31(5), pp. 1604–1616. doi:10.1038/s41591-025-03574-1.
IEEE
L. van Olst et al., “Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease,” Nature Medicine, vol. 31, no. 5, pp. 1604–1616, 2025, doi: 10.1038/s41591-025-03574-1.
BibTeX
@article{vanolst2025microglial,
title = {{Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease}},
author = {van Olst, Lynn and Simonton, Brooke and Edwards, Alex J. and Forsyth, Anne V. and Boles, Jake Sondag and Jamshidi, Pouya and Watson, Thomas H. and Shepard, Nate and Krainc, Talia and Argue, Benney MR and Zhang, Ziyang and Kuruvilla, Joshua and Camp, Lily and Li, Mengwei and Xu, Hang and Norman, Jeanette L. and Cahan, Joshua Gabriel and Vassar, Robert J. and Chen, Jinmiao and Castellani, Rudolph J. and Nicoll, James A. R. and Boche, Delphine and Gate, David},
journal = {Nature Medicine},
year = {2025},
volume = {31},
number = {5},
pages = {1604--1616},
doi = {10.1038/s41591-025-03574-1},
url = {https://doi.org/10.1038/s41591-025-03574-1}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- amyloid-beta clearance
- microglia
- active immunization
- passive immunization
- lecanemab
- TREM2
- apolipoprotein E
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
van Olst, L., Simonton, B., Edwards, A. J., Forsyth, A. V., Boles, J. S., Jamshidi, P., Watson, T. H., Shepard, N., Krainc, T., Argue, B. M., Zhang, Z., Kuruvilla, J., Camp, L., Li, M., Xu, H., Norman, J. L., Cahan, J. G., Vassar, R. J., Chen, J., . . . Gate, D. (2025). Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer’s disease. Nature Medicine, 31(5), 1604–1616. https://doi.org/10.1038/s41591-025-03574-1
How many times has this paper been cited?
185 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Nature Medicine: sign in and open the full text from this page.
Who wrote this paper?
Lynn van Olst, Brooke Simonton, Alex J. Edwards, Anne V. Forsyth, Jake Sondag Boles, Pouya Jamshidi, Thomas H. Watson, Nate Shepard, Talia Krainc, Benney MR Argue, Ziyang Zhang, Joshua Kuruvilla and 11 more.
What is the DOI of this paper?
10.1038/s41591-025-03574-1, permanently at https://doi.org/10.1038/s41591-025-03574-1. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.